2.76 USD
▲-0.16+3.88%
2026-08-03
市值
$13.05M
市盈率
—
EPS
-0.00
股息率
—
52 周区间
2.15 – 4.56
成交量
3.96K
Beta
0.62
目标价
17.50
52W 低 2.1552W 高 4.56
价格走势
公司简介
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applic...